These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16869820)

  • 1. In-hospital cardiac arrest is associated with use of non-antiarrhythmic QTc-prolonging drugs.
    De Bruin ML; Langendijk PN; Koopmans RP; Wilde AA; Leufkens HG; Hoes AW
    Br J Clin Pharmacol; 2007 Feb; 63(2):216-23. PubMed ID: 16869820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death.
    Straus SM; Sturkenboom MC; Bleumink GS; Dieleman JP; van der Lei J; de Graeff PA; Kingma JH; Stricker BH
    Eur Heart J; 2005 Oct; 26(19):2007-12. PubMed ID: 15888497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study.
    Hinterseer M; Thomsen MB; Beckmann BM; Pfeufer A; Schimpf R; Wichmann HE; Steinbeck G; Vos MA; Kaab S
    Eur Heart J; 2008 Jan; 29(2):185-90. PubMed ID: 18156612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic drugs associated with corrected QT interval prolongation.
    van Noord C; Straus SM; Sturkenboom MC; Hofman A; Aarnoudse AJ; Bagnardi V; Kors JA; Newton-Cheh C; Witteman JC; Stricker BH
    J Clin Psychopharmacol; 2009 Feb; 29(1):9-15. PubMed ID: 19142100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do patient characteristics or factors at resuscitation influence long-term outcome in patients surviving to be discharged following in-hospital cardiac arrest?
    Skrifvars MB; Castren M; Nurmi J; Thoren AB; Aune S; Herlitz J
    J Intern Med; 2007 Oct; 262(4):488-95. PubMed ID: 17875186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and determinants of QT interval prolongation in medical inpatients.
    Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
    Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS.
    Asai H; Hirano M; Udaka F; Shimada K; Oda M; Kubori T; Nishinaka K; Tsujimura T; Izumi Y; Konishi N; Matsumoto S; Kameyama M; Ueno S
    J Neurol Sci; 2007 Mar; 254(1-2):78-83. PubMed ID: 17303172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest.
    Mentzelopoulos SD; Zakynthinos SG; Tzoufi M; Katsios N; Papastylianou A; Gkisioti S; Stathopoulos A; Kollintza A; Stamataki E; Roussos C
    Arch Intern Med; 2009 Jan; 169(1):15-24. PubMed ID: 19139319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose.
    Buckley NA; Chevalier S; Leditschke IA; O'Connell DL; Leitch J; Pond SM
    Crit Care; 2003 Oct; 7(5):R101-7. PubMed ID: 12974977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of transport interval on out-of-hospital cardiac arrest survival in the OPALS study: implications for triaging patients to specialized cardiac arrest centers.
    Spaite DW; Stiell IG; Bobrow BJ; de Boer M; Maloney J; Denninghoff K; Vadeboncoeur TF; Dreyer J; Wells GA
    Ann Emerg Med; 2009 Aug; 54(2):248-55. PubMed ID: 19167783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States.
    Enger C; Cali C; Walker AM
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):477-86. PubMed ID: 12426932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sibutramine-associated QT interval prolongation and cardiac arrest.
    Ernest D; Gershenzon A; Corallo CE; Nagappan R
    Ann Pharmacother; 2008 Oct; 42(10):1514-7. PubMed ID: 18728104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of high-risk use of QT-prolonging medications.
    Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High efficacy of beta-blockers in long-QT syndrome type 1: contribution of noncompliance and QT-prolonging drugs to the occurrence of beta-blocker treatment "failures".
    Vincent GM; Schwartz PJ; Denjoy I; Swan H; Bithell C; Spazzolini C; Crotti L; Piippo K; Lupoglazoff JM; Villain E; Priori SG; Napolitano C; Zhang L
    Circulation; 2009 Jan; 119(2):215-21. PubMed ID: 19118258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QTc-prolonging drugs and hospitalizations for cardiac arrhythmias.
    De Bruin ML; Hoes AW; Leufkens HG
    Am J Cardiol; 2003 Jan; 91(1):59-62. PubMed ID: 12505572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with neurologically intact survival for patients with acute heart failure and in-hospital cardiac arrest.
    Levy PD; Ye H; Compton S; Chan PS; Larkin GL; Welch RD;
    Circ Heart Fail; 2009 Nov; 2(6):572-81. PubMed ID: 19919982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Derivation and evaluation of a termination of resuscitation clinical prediction rule for advanced life support providers.
    Morrison LJ; Verbeek PR; Vermeulen MJ; Kiss A; Allan KS; Nesbitt L; Stiell I
    Resuscitation; 2007 Aug; 74(2):266-75. PubMed ID: 17383072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients.
    Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone in cardiac arrest with suspected opioid overdoses.
    Saybolt MD; Alter SM; Dos Santos F; Calello DP; Rynn KO; Nelson DA; Merlin MA
    Resuscitation; 2010 Jan; 81(1):42-6. PubMed ID: 19913979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.